Drug intelligence / Profile preview

Taitai Gubao Granules

Development stage
Unknown
Lead developer
Chengdu Kang'ao Pharmaceutical Research Institute
Modality
Small Molecules
Administration
Oral
01

Overview

Taitai Gubao Granules is a Chinese patent medicine developed by the Chengdu Kang'ao Pharmaceutical Research Institute, primarily indicated for the treatment of postmenopausal osteoporosis. The formulation is based on Traditional Chinese Medicine (TCM) principles, utilizing herbal extracts known for their kidney-tonifying and bone-strengthening properties. It is designed to address the decline in bone mineral density (BMD) associated with estrogen deficiency in postmenopausal women. The drug's mechanism involves the action of phytoestrogens and other bioactive compounds that modulate the balance between osteoblast-led bone formation and osteoclast-led bone resorption. It has undergone clinical evaluation in China to demonstrate its efficacy in reducing bone loss and improving bone quality.

Brand names
Taitai Gubao Granules
Other names
太太骨宝颗粒Gubao Granules
02

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on Taitai Gubao Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taitai Gubao Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call